CNCR vs. EMSF ETF Comparison
Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Matthews Emerging Markets Sustainable Future Active ETF (EMSF)
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$13.22
Average Daily Volume
3,744
67
EMSF
Matthews Emerging Markets Sustainable Future Active ETF
EMSF Description
EMSF actively invests in common and preferred stocks of companies in emerging markets, including countries that may be considered frontier. While the fund has an all-cap exposure, it expects to invest substantially in smaller companies. The fund looks for sustainable growth based on fundamental characteristics such as balance sheet information, size, cash flow stability, and financial health. It also applies various ESG standards, using third-party data and the adviser's proprietary research, to identify investments that potentially contribute to a sustainable future by addressing global environmental and social challenges. The fund also employs exclusionary ESG screens, which avoid controversial businesses such as tobacco, weapons, and fossil fuels. The fund may engage its portfolio companies on sustainability and governance matters through active dialogue, exercising shareholder rights, and encouraging enhanced ESG disclosure.Grade (RS Rating)
Last Trade
$25.90
Average Daily Volume
2,344
3
Performance
Period | CNCR | EMSF |
---|---|---|
30 Days | -13.14% | -5.32% |
60 Days | -15.74% | -1.33% |
90 Days | -11.75% | 0.02% |
12 Months | 25.96% | 0.96% |
1 Overlapping Holdings
Symbol | Grade | Weight in CNCR | Weight in EMSF | Overlap | |
---|---|---|---|---|---|
LEGN | D | 1.1% | 3.91% | 1.1% |
CNCR Overweight 66 Positions Relative to EMSF
Symbol | Grade | Weight | |
---|---|---|---|
GLUE | C | 2.03% | |
EXEL | B | 1.9% | |
RVMD | C | 1.84% | |
ACLX | C | 1.73% | |
BMY | B | 1.72% | |
ELVN | D | 1.68% | |
XNCR | B | 1.66% | |
MRSN | D | 1.62% | |
BPMC | B | 1.58% | |
KPTI | D | 1.57% | |
REPL | D | 1.56% | |
GNLX | F | 1.56% | |
MGNX | F | 1.55% | |
HCM | D | 1.54% | |
SWTX | C | 1.47% | |
CRBU | D | 1.47% | |
JANX | C | 1.46% | |
ERAS | C | 1.46% | |
DAWN | D | 1.44% | |
IMCR | D | 1.42% | |
RXRX | F | 1.39% | |
SDGR | C | 1.39% | |
ARVN | F | 1.39% | |
AURA | C | 1.38% | |
LYEL | F | 1.35% | |
SNDX | F | 1.34% | |
MRUS | F | 1.33% | |
KYMR | D | 1.32% | |
RPTX | F | 1.32% | |
GERN | D | 1.31% | |
IOVA | F | 1.3% | |
RCUS | F | 1.29% | |
NRIX | C | 1.29% | |
FHTX | C | 1.26% | |
NUVB | C | 1.26% | |
BNTX | C | 1.25% | |
ZNTL | F | 1.25% | |
MRK | D | 1.24% | |
BCYC | F | 1.24% | |
YMAB | F | 1.24% | |
BMEA | F | 1.22% | |
PGEN | F | 1.2% | |
CGEM | F | 1.2% | |
ALLO | F | 1.18% | |
NUVL | C | 1.18% | |
VOR | D | 1.17% | |
GMAB | F | 1.17% | |
TYRA | F | 1.16% | |
KURA | F | 1.16% | |
ACRV | F | 1.15% | |
AUTL | F | 1.13% | |
STRO | F | 1.12% | |
IDYA | F | 1.07% | |
TSVT | F | 1.06% | |
REGN | F | 1.0% | |
ITOS | F | 0.98% | |
IPHA | D | 0.98% | |
SMMT | D | 0.97% | |
ACET | F | 0.97% | |
IMRX | F | 0.95% | |
IMTX | F | 0.93% | |
RLAY | F | 0.91% | |
IGMS | F | 0.88% | |
RAPT | F | 0.88% | |
FATE | F | 0.87% | |
PRLD | F | 0.55% |
CNCR: Top Represented Industries & Keywords
EMSF: Top Represented Industries & Keywords